Adam D. Levy

Chief Financial Officer, Acrivon Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.0M

Companies

Latest trade

Aug 4, 2026

Companies

Acrivon Therapeutics, Inc.Chief Financial Officer +$0.0M −$0.0M

Trades

ACRV Sold 1,142 shares at $1.57 $0.0M Aug 4

ACRV Bought 8,832 shares at $1.70 $0.0M Jan 14

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.